Resistance of Hepatitis C Virus to Inhibitors: Complexity and Clinical Implications
Selection of inhibitor-resistant viral mutants is universal for viruses that display quasi-species dynamics, and hepatitis C virus (HCV) is no exception. Here we review recent results on drug resistance in HCV, with emphasis on resistance to the newly-developed, directly-acting antiviral agents, as...
Main Authors: | Celia Perales, Josep Quer, Josep Gregori, Juan Ignacio Esteban, Esteban Domingo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-11-01
|
Series: | Viruses |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4915/7/11/2902 |
Similar Items
-
Pipeline for specific subtype amplification and drug resistance detection in hepatitis C virus
by: María Eugenia Soria, et al.
Published: (2018-09-01) -
Population Disequilibrium as Promoter of Adaptive Explorations in Hepatitis C Virus
by: Carlos García-Crespo, et al.
Published: (2021-04-01) -
Dissimilar Conservation Pattern in Hepatitis C Virus Mutant Spectra, Consensus Sequences, and Data Banks
by: Carlos García-Crespo, et al.
Published: (2020-10-01) -
Hepatitis B and C Virus in Children with Oncohematologic Diseases
by: S.A. Kramarev, et al.
Published: (2016-02-01) -
Cryptolepine and Nibima inhibit hepatitis B virus replication
by: Seth A. Domfeh, et al.
Published: (2021-09-01)